Agilent, GKPC-317, AdvanceBio InstantPC G1 / A2G1 N-glycan standard

AdvanceBio InstantPC G1 / A2G1 N-glycan standard. N-glycan (asialo-, mono-galactosylated biantennary complex) labeled with InstantPC, for use as a qualitative standard in applications such as liquid chromatography (LC) and Mass Spectrometry (MS). Alternative glycan names: NA2G1, A2G(4)1.

Specifications:
Chemical Structure:
Label: InstantPC
Monoisotopic Mass: MWGlycan + 261.14773 = 1739.6871
Name: G1
Oxford Name: A2G1
Standard Type: Complex-type Native N-Glycan
Unit: 25 Injections

**********The following product description is generated by AI and is for reference only. If you have any questions, please contact customer service.**********
This N-glycan standard is a highly purified, well-characterized glycan mixture specifically designed to streamline the analysis of biopharmaceutical glycoproteins. Labeled with InstantPC dye, it provides enhanced fluorescence and mass spectrometry signals, facilitating sensitive and reproducible detection. It includes G1 and A2G1 N-glycan species, making it ideal for benchmarking and quality control in glycan profiling workflows.

Optimized for use with AdvanceBio Glycan Mapping columns, 1290 Infinity LC systems, and compatible capillary electrophoresis and LC-MS setups, this standard enables accurate retention time alignment and system suitability assessment. Researchers in biotherapeutics development, quality assurance, and regulatory compliance can rely on this product for method validation, comparative studies, and glycan release efficiency testing.

Its ready-to-use format minimizes sample preparation time and variability, supporting robust performance in high-throughput environments. The standard is also suitable for assessing system performance in both manual and automated workflows. For a streamlined workflow, use in conjunction with Agilent AdvanceBio InstantPC labeling kits and glycan sample preparation reagents. This product provides confidence in data quality, reproducibility, and overall method reliability for laboratories engaged in in-depth glycan characterization of therapeutic proteins and monoclonal antibodies.